Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: crowd (16), congregation (1), mass (61), multitude (4)

Doctors trial new treatment to improve survival from emergency bowel surgery

Description: Doctors in Southampton are leading a national trial of a treatment approach that could improve survival from emergency bowel surgery by
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/July-2017/Doctors-trial-new-treatment-to-improve-survival-from-emergency-bowel-surgery.aspx

Family fun day for Southampton paediatric IBD patients and their families - 1 July 2017

Description: The paediatric gastroenterology team is hosting a family fun day for families with children whose inflammatory bowel disease is managed at
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/July-2017/Family-fun-day-for-Southampton-paediatric-IBD-patients-and-their-families-1-July-2017.aspx

Southampton clinicians return to Nepal to share research findings

Description: A team of doctors and nurses from Southampton's teaching hospitals have returned to Nepal to share the findings of pioneering research
Url: /AboutTheTrust/Newsandpublications/Latestnews/2017/May-2017/Southampton-clinicians-return-to-Nepal-to-share-research-findings.aspx

Prof Tom Wilkinson, research lead for airways diseases

Description: NIHR Southampton Biomedical Research Centre Auto Generated Title Prof Tom Wilkinson is a clinician and researcher interested in a
Url: /ClinicalResearchinSouthampton/Our-people/Respiratory-research-people/Prof-Tom-Wilkinson-research-lead-for-airways-diseases.aspx

UHS Patient safety incident response plan

Description: Patient safety incident response plan Effective date: 2nd October 2023 Estimated refresh date:2nd October 2024 with informal review after the
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Patient-safety-incident-response-plan.pdf

Tisacel - Cyclophosphamide (500) - Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – TISACEL– CYCLOPHOSPHAMIDE (500) – FLUDARABINE (30) Regimen This regimen wil
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Tisacel-Cyclophosphamide-500-Fludarabine-30-Ver1.pdf

Brexucel - Cyclophosphamide (900) - Fludarabine (25)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY ALL – BREXUCEL – CYCLOPHOSPHAMIDE (900) – FLUDARABINE (25) This regimen will only
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Brexucel-Cyclophosphamide-900-Fludarabine-25.pdf

Tisacel -Cyclophosphamide (250)-Fludarabine (25)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY DLBCL/ FL – TISACEL – FLUDARABINE (25) – CYCLOPHOSPHAMIDE (250) Regimen This regimen will only be avai
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Tisacel-Cyclophosphamide-250-Fludarabine-25.pdf

Tisacel-Bendamustine(90)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY DLBCL/ FL – TISACEL – BENDAMUSTINE (90) Regimen This regimen will only be availabl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Tisacel-Bendamustine90.pdf

InP-ICE-Carboplatin-Etoposide-Ifosfamide

Description: Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE (ICE) Inpatient Regimen Regimen • Lymphoma – InP-ICE-Carboplatin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lym
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-ICE-Carboplatin-Etoposide-Ifosfamide.pdf

91 to 100 of 194

Previous … 8 9 10 11 12 … Next